David Kirske - Dec 29, 2022 Form 4 Insider Report for CTI BIOPHARMA CORP (CTIC)

Role
EVP, Chief Financial Officer
Signature
David Kirske
Stock symbol
CTIC
Transactions as of
Dec 29, 2022
Transactions value $
-$272,190
Form type
4
Date filed
1/3/2023, 05:36 PM
Previous filing
Oct 6, 2022
Next filing
Mar 16, 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CTIC common stock Options Exercise $12.5K +13.2K +77.89% $0.95* 30.1K Dec 29, 2022 Direct
transaction CTIC common stock Sale -$79K -13.2K -43.79% $6.00 16.9K Dec 29, 2022 Direct F1
transaction CTIC common stock Award $1.09K +214 +1.27% $5.11 17.1K Dec 30, 2022 Direct F2
transaction CTIC common stock Options Exercise $11.4K +12K +70.06% $0.95* 29.1K Dec 30, 2022 Direct
transaction CTIC common stock Sale -$72K -12K -41.2% $6.00 17.1K Dec 30, 2022 Direct F1
transaction CTIC common stock Options Exercise $759 +800 +4.67% $0.95* 17.9K Dec 30, 2022 Direct
transaction CTIC common stock Sale -$4.8K -800 -4.46% $6.01 17.1K Dec 30, 2022 Direct F1
transaction CTIC common stock Options Exercise $993 +1.05K +6.11% $0.95* 18.2K Dec 30, 2022 Direct
transaction CTIC common stock Sale -$6.29K -1.05K -5.76% $6.01 17.1K Dec 30, 2022 Direct F1
transaction CTIC common stock Options Exercise $25.6K +27K +157.77% $0.95* 44.1K Jan 3, 2023 Direct
transaction CTIC common stock Sale -$162K -27K -61.21% $6.01 17.1K Jan 3, 2023 Direct F1, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CTIC Non-Qualified Stock Option (right to buy) Options Exercise $0 -13.2K -4.06% $0.00 311K Dec 29, 2022 Common Stock 13.2K $0.95 Direct F4
transaction CTIC Non-Qualified Stock Option (right to buy) Options Exercise $0 -12K -3.86% $0.00 299K Dec 30, 2022 Common Stock 12K $0.95 Direct F4
transaction CTIC Non-Qualified Stock Option (right to buy) Options Exercise $0 -800 -0.27% $0.00 298K Dec 30, 2022 Common Stock 800 $0.95 Direct F4
transaction CTIC Non-Qualified Stock Option (right to buy) Options Exercise $0 -1.05K -0.35% $0.00 297K Dec 30, 2022 Common Stock 1.05K $0.95 Direct F4
transaction CTIC Non-Qualified Stock Option (right to buy) Options Exercise $0 -27K -9.09% $0.00 270K Jan 3, 2023 Common Stock 27K $0.95 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This sale was effected pursuant to a 10b5-1 sales plan adopted by the Reporting Person.
F2 Shares acquired under the CTI BioPharma Corp. 2007 Employee Stock Purchase Plan.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.00 to $6.07, inclusive. The reporting person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
F4 One third of the shares underlying the option vested on 2/19/20 and annually thereafter until all the underlying shares were fully vested on 2/19/2022.